SEE FULL COMPANY PROFILES WITH A FREE TRIAL
EMIS is the definitive emerging markets news, research, company, and financial data resource. EMIS - ISI Emerging MarketsLEARN MORE
Search for another company:
ALL
Thailand
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).

Pfizer Thailand Limited

Main Activities: Chemical Manufacturing

facebook Please check the full coverage of information what EMIS can offer you. SEE SAMPLE

Company Information

Full name
Pfizer Thailand Limited

Headquarters
323 Silom Road,Silom, Bangrak ; Bangkok , Special Governed District of ; Central Thailand; 10500
Status: Non-Listed
Legal Form: Limited Liability Company
Operational Status: Operational
Financial Auditors: KPMG (2011)
Incorporation Date: August 16, 1968
Total Employees: 521

Tel: 662 665 4555

Company Description

Pfizer (Thailand) was established in 1958 by Pfizer Inc., which has its head office in New York, USA. At present, Pfizer (Thailand) has 468 employees working in various departments – sales, marketing, medical research, human resources, business technology relations, business and corporate affairs, and finance. We also have business affiliates, including the Animal Health Group, Capsule Gel Co., Ltd. and Adams Co., Ltd. Pfizer has established our business operations in Thailand. We has provided
More

Company Analysis

According to the Individual - Audited financial statement for the Year of 2010, total net operating revenues increased with 16.72%, from THB 843.62 tens of millions to THB 984.71 tens of millions. Operating result increased from THB 166.68 tens of millions to THB 182.68 tens of millions which means 9.60% change. The results of the period increased 8.61% reaching THB 121.21 tens of millions at the end of the period against THB 111.6 tens of millions last year. Return on equity (Net income/Total equity) went from 93.46% to 50.37%, the Return On Asset (Net income / Total Asset) went from 21.59% to 17.31% and the Net Profit Margin (Net Income/Net Sales) went from 13.23% to 12.31% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 191.01% compared to 332.84% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 1.27 to 1.30 when compared to the previous year.

Key Executives

Companies with Similar Main Activities

ISI Emerging Markets

FULL COMPANY PROFILE

Please check the full coverage of information what EMIS can offer you.
SEE SAMPLE
SELECT CURRENCY
2011 Y
(non-cons)
Audited
CEIC
Unit Tens of Millions)